🔍

Medi Caps Ltd (523144)

📊 BSE: 523144 🏢 Pharmaceuticals 📢 Latest filing: 23 Sep 2026

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Medi Caps' revenue was ₹2.8 Cr (+3.6% year on year, -19.2% on the previous quarter), and net profit ₹-2.2 Cr (a smaller loss than a year earlier); the operating margin was -65.7%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹2.8	+3.6%	-19.2%
Operating profit	₹-1.8	loss narrowed	loss narrowed
Net profit	₹-2.2	loss narrowed	to loss
EPS (₹)	-1.79	loss narrowed	to loss
Operating margin	-65.7%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Medi-Caps AGM Approves 3-Year Re-Appointment of CMD and Appointment of Whole-Time Woman Director

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 23 Sep 2026, 04:01 PM

Medi-Caps shareholders at the 43rd AGM on September 22, 2026, confirmed the re-appointment of Mr. Alok K Garg as Chairman and Managing Director for a 3-year term from September 1, 2026, to August 31, 2029. Shareholders also approved the appointment of Mrs. Saloni Garg as Director and Whole-Time Woman Director for 3 years effective August 7, 2026, to August 6, 2029. The filing discloses that Mrs. Saloni Garg is the daughter-in-law of Mr. Alok K Garg. The micro-cap company currently operates with TTM revenues of Rs 13 Cr and reported a TTM net loss of Rs 2 Cr.

Shareholder confirmation of Mr. Alok K Garg's re-appointment as CMD for 3 years (01-Sep-2026 to 31-Aug-2029)
Confirmation of Mrs. Saloni Garg as Whole-Time Woman Director for 3 years (07-Aug-2026 to 06-Aug-2029)
Related-party disclosure: Mrs. Saloni Garg is the daughter-in-law of CMD Mr. Alok K Garg
43rd Annual General Meeting held on September 22, 2026 (12:30 PM to 12:50 PM)

💡 Track subsequent quarterly results to see if board changes translate into operational turnaround given the negative operating margins.

Medi-Caps Shareholders Approve All 3 Resolutions at 43rd AGM with 98.77% Majority

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 23 Sep 2026, 03:43 PM

Medi-Caps Limited announced the voting results of its 43rd Annual General Meeting held on September 22, 2026. Shareholders approved all three resolutions with a 98.77% majority of total votes polled. The passed items include the adoption of FY26 financial statements, the re-appointment and remuneration of CMD Alok K Garg, and the appointment of Saloni Garg as Whole-Time Woman Director. Notably, 92.89% of the polled non-institutional public votes (80,000 shares) were cast against all three resolutions, but promoter support secured approval.

All 3 resolutions approved with 98.7694% overall votes in favour (64,20,981 votes)
Total votes polled stood at 65,00,981, representing 52.1332% of total outstanding shares
CMD Alok K Garg re-appointed and Saloni Garg confirmed as Whole-Time Woman Director
80,000 public non-institutional votes (92.885% of public votes polled) voted against all resolutions

💡 Track upcoming Q2 FY27 earnings to see if operational performance improves, following FY26 net losses of Rs 3.04 Cr.

Medi Caps Schedules 43rd AGM for Sep 22, 2026; E-Voting Cut-Off on Sep 15

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 25 Aug 2026, 12:24 PM

Medi Caps Limited has announced the details for its 43rd Annual General Meeting (AGM), scheduled to take place on September 22, 2026, via Video Conferencing. The cut-off date for determining shareholders eligible for e-voting is September 15, 2026. The remote e-voting period opens on September 19, 2026 (9:00 AM) and closes on September 21, 2026 (5:00 PM). A total of 3 resolutions will be voted upon during this meeting.

43rd Annual General Meeting scheduled for Tuesday, September 22, 2026, at 12:30 PM IST via VC/OAVM
Cut-off date for e-voting entitlement fixed as September 15, 2026
Remote e-voting window runs from September 19, 2026 (9:00 AM) to September 21, 2026 (5:00 PM)
Total of 3 resolutions to be placed before the members

💡 Eligible shareholders holding shares on the cut-off date (September 15, 2026) may review the AGM agenda and participate in remote e-voting prior to the AGM.

Medi-Caps Dispatches AGM Notice and FY26 Annual Report Access Letter to Shareholders

🟡 NEUTRAL ⭐ 1/10

ROUTINE 📅 25 Aug 2026, 12:17 PM

Medi-Caps Limited has issued a draft communication to shareholders whose email addresses are not registered with the company or depositories. The letter provides web links to access the FY2025-26 Annual Report and notice for the upcoming 43rd Annual General Meeting (AGM). The AGM is scheduled to be held on September 22, 2026, at 12:30 PM via Video Conferencing.

43rd Annual General Meeting scheduled for September 22, 2026, at 12:30 PM via Video Conferencing
Communication dispatched under Regulation 36(1)(b) of SEBI LODR Regulations for FY2025-26 Annual Report
Physical or unregistered holders directed to update details with RTA Ankit Consultancy Private Limited

💡 Shareholders without registered email addresses should update their records with the RTA or depository to receive electronic communications and AGM voting access.

Medi Caps Submits FY26 Annual Report; 43rd AGM Scheduled for Sept 22, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 25 Aug 2026, 12:09 PM

Medi Caps has released its 43rd Integrated Annual Report for FY 2025-26 and scheduled its AGM for September 22, 2026. The meeting notice seeks shareholder approval for the reappointment of Mr. Alok K. Garg as Chairman & MD at a monthly salary of Rs 7,00,000 for three years effective September 1, 2026. Additionally, the AGM will vote on confirming the appointment of Mrs. Saloni Garg as Whole-Time Woman Director at a monthly salary of Rs 2,00,000. Key board changes include the resignations of Chairman Ramesh Chandra Mittal and Director Kusum Mittal on August 6, 2026.

43rd Annual General Meeting scheduled for September 22, 2026 via Video Conferencing
Proposed reappointment of Mr. Alok K. Garg as CMD for 3 years with monthly salary of Rs 7,00,000 plus perquisites up to 25%
Appointment confirmation sought for Mrs. Saloni Garg as Whole-Time Director for 3 years at Rs 2,00,000 per month
Board departures noted: Chairman Ramesh Chandra Mittal and Director Kusum Mittal resigned effective August 6, 2026
Mr. Akshit Garg appointed as Chief Financial Officer effective August 7, 2026

💡 Track voting outcomes of the AGM resolutions on September 22, 2026, and monitor subsequent quarterly operational performance amid ongoing net losses.

Medi Caps Convenes 43rd AGM on Sep 22, 2026; Proposes CMD and Director Re-appointments

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 25 Aug 2026, 11:47 AM

Medi Caps Limited has issued the notice for its 43rd Annual General Meeting (AGM) scheduled for September 22, 2026, via Video Conferencing. Key agenda items include the adoption of FY26 financial statements, the re-appointment of Mr. Alok K Garg as Chairman & Managing Director for three years at a monthly salary of Rs. 7,00,000 plus perquisites (up to 25%), and the confirmation of Mrs. Saloni Garg as Whole-Time Woman Director for three years at Rs. 2,00,000 per month plus perquisites. The total base remuneration of Rs. 1.08 Cr per annum represents ~8.3% of the company's TTM revenue of Rs. 13 Cr.

43rd AGM scheduled to be held on September 22, 2026, at 12:30 PM (IST) via VC/OAVM.
Proposed re-appointment of Mr. Alok K Garg as CMD for 3 years (Sep 1, 2026 to Aug 31, 2029) at Rs. 7,00,000 per month.
Proposed appointment of Mrs. Saloni Garg as Whole-Time Woman Director for 3 years (Aug 7, 2026 to Aug 6, 2029) at Rs. 2,00,000 per month.
Perquisites for both managerial positions capped at 25% of annual salary with minimum remuneration clauses in case of loss or inadequate profits.

💡 Track shareholder voting results and scrutinizer reports following the AGM on September 22, 2026, alongside upcoming Q2 FY27 earnings performance.

Medi Caps Ltd Announces Resignation of Chairperson and Appointment of New CFO

🟡 NEUTRAL ⭐ 7/10

MANAGEMENT 📅 08 Aug 2026, 03:23 PM

Medi Caps Ltd has reported significant leadership changes, including the resignation of its Chairperson, Mr. Ramesh Chandra Mittal, effective August 6, 2026. Mr. Akshit Garg has been appointed as the new Chief Financial Officer (CFO) effective August 7, 2026, filling the vacancy left by Mr. Hemant Sethi who resigned in June 2026. These changes occur as the company faces financial pressure, with TTM revenue declining to ₹12 Cr from ₹25.48 Cr in FY25 and a TTM net loss of ₹3 Cr. The board has also updated its authorized personnel for determining material disclosures under SEBI regulations.

Mr. Ramesh Chandra Mittal resigned as Chairperson and Non-Executive Director effective August 6, 2026
Mr. Akshit Garg appointed as Chief Financial Officer (CFO) effective August 7, 2026
Previous CFO Mr. Hemant Sethi resigned from the position effective June 6, 2026
Company reported a TTM revenue of ₹12 Cr against a market cap of ₹34 Cr
Authorization for materiality determination now rests with Alok K Garg (CMD), Akshit Garg (CFO), and Abhishek Kumar (CS)

💡 Investors should monitor the new CFO's impact on financial discipline and the company's ability to arrest the ~50% year-on-year revenue decline seen in FY26.

Medi Caps Ltd Appoints New CFO and Whole Time Director; Re-appoints CMD for 3 Years

🟡 NEUTRAL ⭐ 7/10

MANAGEMENT 📅 06 Aug 2026, 05:12 PM

Medi Caps Ltd has announced a significant management restructuring, re-appointing Mr. Alok K. Garg as Chairman and Managing Director for a three-year term starting September 1, 2026. The board also appointed Mr. Akshit Garg as the new Chief Financial Officer and Mrs. Saloni Garg as a Whole Time Woman Director, effective August 7, 2026. These appointments come as the company faces financial headwinds, with TTM revenue declining to Rs 12 crore and operating margins at -75.5%. The leadership remains concentrated within the promoter family, as the CMD is the father-in-law of the new Whole Time Director.

Re-appointment of Mr. Alok K. Garg as CMD for a 3-year term from September 2026 to August 2029
Appointment of Mr. Akshit Garg as CFO and KMP effective August 7, 2026
Appointment of Mrs. Saloni Garg as Whole Time Woman Director for a 3-year term
Company reported a TTM net loss of Rs 3 crore on a revenue base of Rs 12 crore
Promoter holding remains stable at 51.44% as of June 2026

💡 Investors should monitor whether this leadership team can execute a turnaround, specifically focusing on improving the operating profit margin which stood at -75.66% for FY26.

Medi Caps Ltd Appoints New CFO and Re-appoints MD for 3-Year Term

🟡 NEUTRAL ⭐ 7/10

MANAGEMENT 📅 06 Aug 2026, 05:08 PM

Medi Caps Ltd has announced a significant leadership reshuffle, re-appointing Mr. Alok K. Garg as Chairman and Managing Director for a three-year term starting September 1, 2026. The board also appointed Mr. Akshit Garg as the new CFO and Mrs. Saloni Garg as a Whole Time Woman Director, effective August 7, 2026. These changes occur as the company faces financial stress, with TTM revenue declining to Rs 12 Cr and operating margins at -75.5%. The appointments consolidate family management, as Mrs. Saloni Garg is the daughter-in-law of the MD.

Re-appointment of Alok K. Garg as Chairman and MD for a 3-year term (2026-2029)
Appointment of Akshit Garg as CFO and KMP effective August 7, 2026
Appointment of Saloni Garg as Whole Time Woman Director for a 3-year term
Company reported a significant revenue drop from Rs 25.48 Cr in FY25 to Rs 12.45 Cr in FY26
Operating profit margin remains deeply negative at -75.5% for the trailing twelve months

💡 Investors should monitor whether this leadership team can arrest the 50% year-on-year revenue decline and utilize the company's substantial net worth of Rs 112 Cr to generate positive ROCE.

Medi Caps Re-appoints Alok K. Garg as CMD; Appoints New CFO and Woman Director

🟡 NEUTRAL ⭐ 7/10

MANAGEMENT 📅 06 Aug 2026, 05:07 PM

Medi Caps Ltd has announced a leadership reshuffle, re-appointing Mr. Alok K. Garg as Chairman cum Managing Director for a three-year term effective September 1, 2026. The board also appointed Mr. Akshit Garg as CFO and Mrs. Saloni Garg (daughter-in-law of the CMD) as a Whole Time Woman Director, both effective August 7, 2026. These changes come as the company faces financial stress, with a TTM revenue of just Rs 12 cr and an operating margin of -75.5%. The appointments are subject to shareholder approval at the upcoming 43rd Annual General Meeting.

Re-appointment of Mr. Alok K. Garg as CMD for a 3-year term from September 1, 2026, to August 31, 2029
Appointment of Mr. Akshit Garg as CFO and KMP effective August 7, 2026, citing 8 years of experience in finance
Appointment of Mrs. Saloni Garg as Whole Time Woman Director for a 3-year term starting August 7, 2026
Company reported a TTM net loss of Rs 3 cr against a market capitalization of Rs 33 cr
Promoter holding remains stable at 51.44% as of June 2026

💡 Investors should monitor the upcoming 43rd AGM for shareholder approval of these appointments and watch for any strategic shifts aimed at correcting the -75.5% operating margin.

Medi Caps Ltd Appoints New CFO and Whole Time Director; Re-appoints CMD for 3 Years

🟡 NEUTRAL ⭐ 7/10

MANAGEMENT 📅 06 Aug 2026, 05:04 PM

Medi Caps Ltd has announced a leadership reshuffle, appointing Mr. Akshit Garg as Chief Financial Officer (CFO) effective August 7, 2026. The board also re-appointed Mr. Alok K. Garg as Chairman and Managing Director for a three-year term starting September 1, 2026. Additionally, Mrs. Saloni Garg has been appointed as a Whole Time Woman Director for three years. These changes occur as the company faces financial challenges, with TTM revenue of Rs 12 crore and a net loss of Rs 3 crore.

Appointment of Mr. Akshit Garg as CFO and KMP effective August 7, 2026.
Re-appointment of Mr. Alok K. Garg as CMD for a 3-year term ending August 31, 2029.
Appointment of Mrs. Saloni Garg as Whole Time Woman Director for a 3-year term.
Mr. Akshit Garg brings over 8 years of experience in Finance, Marketing, and Real Estate.
Mrs. Saloni Garg is the daughter-in-law of the CMD, Mr. Alok K. Garg.

💡 Investors should monitor if the new management team can address the company's significant operating losses (OPM of -75.5%) and the 51% decline in annual revenue from FY25 to FY26.

Medi Caps Reports Q1 Net Loss of ₹2.23 Cr; Appoints New CFO and Director

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 06 Aug 2026, 04:54 PM

Medi Caps Ltd reported a consolidated net loss of ₹2.23 Cr for the quarter ended June 30, 2026, narrowing from a loss of ₹3.49 Cr in the same period last year. Consolidated revenue remained stagnant at ₹2.79 Cr, with the Pharma division contributing 96% of the total. The company also announced a management reshuffle, appointing Akshit Garg as CFO and Saloni Garg as a Whole Time Director. Despite a substantial net worth of ₹112 Cr, the company continues to face operational challenges with negative segment results across both Pharma and Real Estate divisions.

Consolidated net loss narrowed to ₹2.23 Cr from ₹3.49 Cr in the year-ago quarter.
Pharma division revenue stood at ₹2.68 Cr, accounting for nearly all operational income.
Real Estate division revenue dropped to ₹0.10 Cr from ₹0.53 Cr in the preceding March quarter.
Akshit Garg appointed as Chief Financial Officer (CFO) effective August 7, 2026.
Alok K. Garg re-appointed as Chairman and Managing Director for a 3-year term starting September 2026.

💡 Investors should monitor the company's ability to scale its Pharma subsidiary, Medgel Private Limited, and the pace of inventory liquidation in its Real Estate project (Medi-caps Business Park) to achieve break-even.

Medi Caps Q1 Net Loss Narrows to 2.23 Cr; Appoints New CFO and Whole Time Director

🟡 NEUTRAL ⭐ 6/10

EARNINGS 📅 06 Aug 2026, 04:48 PM

Medi Caps reported a consolidated net loss of 2.23 Cr for Q1 FY27, showing improvement from a 3.49 Cr loss in the year-ago period. Consolidated revenue for the quarter stood at 2.79 Cr, with the Pharma division contributing 96% of the total. The company also announced a management reshuffle, appointing Akshit Garg as CFO and Saloni Garg as a Whole Time Director. Despite the narrowing loss, both the Pharma and Real Estate segments remain loss-making at the operational level.

Consolidated net loss narrowed to 2.23 Cr in Q1 FY27 from 3.49 Cr in Q1 FY26
Pharma division revenue remained steady at 2.68 Cr compared to 2.69 Cr YoY
Real Estate segment generated minimal revenue of 10.49 Lacs from the sale of shops
Akshit Garg appointed as Chief Financial Officer (CFO) effective August 7, 2026
Alok K. Garg re-appointed as Managing Director for a 3-year term starting September 2026

💡 Monitor the Pharma division's ability to reach break-even, as it currently reports a segment loss of 1.64 Cr. Investors should also track the 43rd AGM on September 22, 2026, for updates on the Real Estate monetization strategy.

Resignation of Chairman Ramesh Chandra Mittal and Director Kusum Mittal effective Aug 6, 2026

🟡 NEUTRAL ⭐ 5/10

MANAGEMENT 📅 30 Jul 2026, 01:23 PM

Medi Caps Ltd has announced the resignation of its Chairman, Mr. Ramesh Chandra Mittal, and Non-Executive Director, Mrs. Kusum Mittal, effective August 6, 2026. Both directors cited personal health concerns as the reason for their departure. This leadership change occurs as the company faces significant financial headwinds, with TTM revenue falling to Rs 12 Cr from Rs 25.48 Cr in FY25. The company is currently loss-making with a TTM PAT of Rs -3 Cr and a highly negative operating margin of -75.5%.

Resignation of Chairman Mr. Ramesh Chandra Mittal effective from the close of business hours on 06th August, 2026.
Resignation of Non-Executive Director Mrs. Kusum Mittal effective from the close of business hours on 06th August, 2026.
Company TTM revenue of Rs 12 Cr represents a sharp decline from FY25 revenue of Rs 25.48 Cr.
Operating Profit Margin (OPM) remains deeply negative at -75.5% for the trailing twelve months.
Promoter holding remains stable at 51.44% as of June 2026.

💡 Investors should monitor the upcoming Board Meeting for the appointment of a new Chairperson and any strategic updates regarding the company's turnaround plan given the 50% year-on-year revenue decline.

Resignation of Chairperson Ramesh Chandra Mittal and Director Kusum Mittal

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 30 Jul 2026, 01:17 PM

Medi Caps Ltd has announced the resignation of its Chairperson, Mr. Ramesh Chandra Mittal, and Non-Executive Director, Mrs. Kusum Mittal, effective August 6, 2026. Both directors cited personal health concerns as the primary reason for their departure. This leadership change comes at a time when the company is struggling financially, reporting a TTM revenue of just Rs 12 Cr and a net loss of Rs 3 Cr. The company currently operates with a negative operating margin of -75.5% and a market capitalization of Rs 34 Cr.

Chairperson Ramesh Chandra Mittal to step down effective August 6, 2026
Non-Executive Director Kusum Mittal to step down effective August 6, 2026
Resignations attributed to personal health concerns with no other material reasons cited
Company reported a net loss of Rs 3.04 Cr for FY26 on revenue of Rs 12.45 Cr
Promoter holding remains stable at 51.44% as of June 2026

💡 Investors should monitor the appointment of a new Chairperson and any subsequent changes in the company's turnaround strategy, given its current loss-making status and negative ROCE of -2.6%.

View All 523144 Announcements on Live Market Tracking →